The Phase 1 clinical trial of the Chinese Institute of Medical Biology experimental vaccine has been completed.
REPUBLIKA.CO.ID, JAKARTA – Vaccines Covid-19 The Chinese experimental developed by the Institute of Medical Biology appears to be safe in early-stage clinical trials, according to the researchers. The Institute is an institution under the Chinese Academy of Medical Sciences.
The Phase 1 clinical trial involved 191 healthy participants aged 18 to 59 years. The experimental vaccine injection in the group did not show a severe negative reaction, the Institute said through documents uploaded in preprinted journals. medRxiv, Tuesday.
The most common negative reactions experienced by participants were mild pain, slight fatigue and redness, and itching and swelling at the injection site. The experimental vaccine also triggers an immune response.
“All the data obtained from this clinical trial supports the safety and immunity of this inactivated vaccine and also encourages further research on the efficacy of the vaccine going forward,” the document states.
China is injecting hundreds of thousands of essential workers and other groups deemed particularly at risk with other vaccines, even as clinical trials are not yet fully completed, which has raised concerns among experts.
At least four experimental vaccines made in China are currently in the final stages of clinical trials.